(Q38811818)

6 September 2017

MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer (English)

1 reference

6 September 2017

Zhen-Hua Wu

1

1 reference

6 September 2017

Zhong-Hua Tao

2

1 reference

6 September 2017

Jian Zhang

3

1 reference

6 September 2017

Ting Li

4

1 reference

6 September 2017

Chen Ni

5

1 reference

6 September 2017

Jie Xie

6

1 reference

6 September 2017

Jin-Feng Zhang

7

1 reference

6 September 2017

Xi-Chun Hu

8

1 reference

6 September 2017

14 December 2015

1 reference

6 September 2017

1 reference

6 September 2017

37

1 reference

6 September 2017

6

1 reference

6 September 2017

7245-7254

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-4604-7

6 September 2017

0 references

cites work

Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Cellular pharmacology of gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Gemcitabine resistance in pancreatic cancer: picking the key players

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Liver kinase B1 enhances chemoresistance to gemcitabine in breast cancer MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Cancer drug resistance: an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Epithelial-mesenchymal transitions in development and pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Sequence analysis of mutations and translocations across breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Epithelial to mesenchymal transition and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Regulatory networks defining EMT during cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4604-7

10.1007/S13277-015-4604-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference